Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
about
Meeting report of the 8th International Conference on cGMP "cGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017.Clinical and pathological characteristics of IgG4-related interstitial lung disease.C-Type Natriuretic Peptide (CNP) Inhibition of Interferon-γ-Mediated Gene Expression in Human Endothelial Cells In Vitro
P2860
Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@en
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@nl
type
label
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@en
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@nl
prefLabel
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@en
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@nl
P2093
P2860
P921
P1433
P1476
Atrial natriuretic peptide pro ...... : ANP for pulmonary fibrosis.
@en
P2093
Atsuko Okamoto
Hiroshi Hosoda
Kazuhisa Asai
Kazuhisa Konishi
Kazuto Hirata
Kenji Kangawa
Koichi Miura
Mikiya Miyazato
Takashi Nojiri
Takeshi Tokudome
P2860
P2888
P356
10.1186/S12931-016-0492-7
P50
P577
2017-01-03T00:00:00Z
P6179
1007523825